Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
69 Cards in this Set
- Front
- Back
NEUROLOGY PHARMACOLOGY
|
|
|
What is the underlying cause of Parkinson's?
|
loss of dopaminergic neurons and excess cholinergic activity
|
|
Mneumonic for Parkinson's Disease drugs?
|
BALSA: Bromocriptine, Amantiadine, Levodopa (+carbidopa), Selegiline (+COMT inhibitors), Antimuscarinics
|
|
MOA of Bromocriptine?
|
agonize dopamine receptors (ergot alkaloid and partial dopamine agonist)
|
|
Agents that increase dopamine?
|
Amantadine (increase dopamine release), L-dopa/carbidopa(converted to dopamine in CNS)
|
|
MOA of Selegiline and entacapone/tolcapone?
|
Prevent dopamine breakdown (Selegiline=selective MAO type B inhibitor)and (entacapone/tolcapone=COMT inhibitors)
|
|
MOA of Benztropine?
|
Curbs excess cholinergic activity (antimuscarinic)
|
|
Antimuscarinic that improves tremor and rigidity but has little effect on bradykinesia?
|
Benztropine
|
|
Clinical use of L-dopa/carbidopa?
|
Parkinsonism
|
|
MOA of L-dopa/carbidopa?
|
Increase dopamine levels in brain. Cross BBB and converted by dopa decarboxylase in CNS to dopamine.
|
|
Toxicity of L-dopa?
|
Arrhythmias from peripheral conversion to dopamine; dyskinesia after doses and akinesia between doses.
|
|
How can you avoid L-dopa induced arrhythmias?
|
Give with carbidopa = a peripheral decarboxylase inhibitor
|
|
Selegiline MOA?
|
Inhibits MAO-B; increase dopamine availability
|
|
Selegiline toxicity?
|
enhance adverse effects of L-dopa
|
|
Sumatriptin MOA?
|
5-HT1D agonist. Causes vasoconstriction.
|
|
Clinical use of Sumatriptin?
|
acute migraine, cluster headaches
|
|
Sumatriptin toxicity and contraindications?
|
coronary vasospasm; contraindicated in pts with CAD or angina
|
|
Clinical use of phenytoin?
|
1st line for generalized tonic-clonic seizures and status epilepticus prophylaxis. Also a class IB antiarrhythmic.
|
|
MOA of phenytoin?
|
increase Na+ channel inactivation. Inhibits glutamate (excitatory) release.
|
|
Clinical use of Carbamazepine?
|
1st line for generalized tonic-clonic seizures and trigeminal neuralgia. Also for simple and complex partial seizures.
|
|
MOA of Carbamazepine?
|
increase Na+ channel inactivation
|
|
Toxicity of Carbamazepine?
|
diplopia, atazia, agranulocytosis, aplastic anemia, liver toxicity, teratogenesis, induces cyto P-450
|
|
Toxicity of phenytoin?
|
nystagmus, diplopia, ataxia, sedation, gingival hyperplasia, hirsutism, megaloblastic anemia, teratogenesis, malignant hyperthermia, SLE-like syndrome, induces cyto P-450
|
|
Lamotrigine MOA?
|
blocks voltage-gaated Na+ channels
|
|
Clinical use Gabapentin?
|
simple and complex partial seizures; generalized tonic-clonic. Also peripheral neuropathy.
|
|
MOA of Gabapentin?
|
increase GABA release
|
|
Topiramate MOA?
|
blocks Na+ channels, increase GABA action
|
|
Gabapentin toxicity?
|
sedation, ataxia
|
|
Lamotrigine toxicity?
|
Stevens-Johnson syndrome.
|
|
Topiramete toxicity?
|
sedation, mental dulling, kidney stones, weight loss
|
|
Phenobarbital clinical use?
|
1st line in preggers and kids. Generalized tonic-clonic and simple and complex partial seizures.
|
|
Barbituate toxicity?
|
sedation, tolerance, dependence, cyto P-450 induction, resp/CV depression, additive with alcohol
|
|
Barbituate MOA?
|
increases GABA-A action by increase DURATION of Cl- channel opening, which decreases neuron firing. [barbiDURATe=increased DURATion]
|
|
Valproic acid clinical use?
|
1st line for generalized tonic-clonic seizures. Also for myoclonic and absence seizures.
|
|
Valproic acid MOA?
|
increase Na+ channel inactivation. Increase GABA concentration.
|
|
Valproic acid toxicity?
|
GI distress, fatal hepatotoxicity, neural tube defects, tremor, weight gain
|
|
Ethosuximide clinical use?
|
1st line for absence seizures.
|
|
MOA ethosuximide?
|
blocks thalamice T-type Calcium channels
|
|
Ethosuximide toxicity?
|
GI distress, lethargy, headache, urticaria, Stevens-Johnson syndrome
|
|
Benzodiazepine clinical uses?
|
1st line for acute status epilepticus; also for seizures of eclampsia
|
|
Name 4 barbituates.
|
Phenobarbital, pentobarbital, thiopental, secobarbital
|
|
Barbituate contraindication?
|
porphyria
|
|
Name some Benzodiazepines. (8)
|
diazepam, lorazepam, triaxolam, temazepam, oxazepam, midazolam, chlordiazepoxide, alpraxolam
|
|
MOA of Benzos?
|
Facilitate GABA-A action by increse FREQUENCY of Cl- channel opening
|
|
What drug class do you use for alcohol withdrawal-DTs?
|
Benzos
|
|
What are the 3 short-acting Benzos?
|
TOM thumb= Triazolam, Oxazepam, Midazolam
|
|
Do benzos or barbituates have a higher risk of resp depression and coma?
|
Barbituates
|
|
How do you treat a Benxo overdose?
|
Flumazenil (competitive antagonist at GABA receptor)
|
|
Name 6 inhaled anesthetics
|
halothane, enflurane, isoflurane, sevoflurane, methoxyflurane, nitrous oxide
|
|
Effects of inhaled anesthetics?
|
myocardial and resp depression, nausea/emesis, increase cerebral blood flow
|
|
Toxicity of halothane, methoxyflurane, and enflurane?
|
hepatotoxicity (halothane), nephrotoxicity (methoxyflurane), proconvulsant (enflurane)
|
|
Drug classes used as IV anesthetics? (5)
|
Barbiturates, Benzos, Ketamine, Opiates, Propofol
|
|
Name the local anesthetics that are esters
|
procaine, cocaine, tetracaine, amides
|
|
Name the local anesthetics that are amides
|
lidocaine, mepivacaine, bupivacaine
|
|
barbiturate used as IV anesthetic?
|
thiopental - used for short surgical procedures and induction of anesthesia
|
|
drug used for endoscopy?
|
midazolam
|
|
Arrylcyclohexamine (ketamine) effects?
|
CV stimulant, disorientation, hallucination, bad dreams, increase cerebral blood flow
|
|
Opeates used during general anesthesia?
|
morphine, fentanyl
|
|
MOA of local anesthetics?
|
block Na+ channels. Tertiary amines penetrate membrane in uncharged form, then bind to ion channels as charged form.
|
|
Order of nerve block?
|
small diameter>large diameter. Myelinated>unmyelinated. Size predominates over myelination.
|
|
order of loss during nerve block?
|
pain(1st)>temp>touch>pressure
|
|
how do you enhance local action?
|
give with vasoconstrictors (EPI)
|
|
What happens to local anesthetics in infected tissues?
|
tissue is acidic; anesthetics are charged and can't penetrate membrane. More anesthetic is needed.
|
|
What receptor do neuromuscular blocking drugs target and what are they used for clinically?
|
motor (vs. autonomic) nicotinic receptor. Used for muscle paralysis in surgery or mechanical ventilation.
|
|
Depolarizing neuromuscular blocking drug?
|
succinylcholine
|
|
nondepolarizing neuromuscular blocking drugs?
|
tubocurarine, atracurium, mivacurium, pancuronium, vecuronium, rapacuronium
|
|
What is dantrolene used for?
|
treatment of malignant hyperthermia and neuroleptic malignant syndrome
|
|
MOA of dantrolene?
|
prevents release of calcium from the SR of skeletal muscle
|
|
How do you reverse blockade of nondepolarizing neuromuscular blocking drugs?
|
neostigmine, edrophonium, and other cholinesterase inhibitors
|